Physician profile

Daniel A Hoit

Neurological Surgery · Memphis, TN

NPI 1902000698

$606,651.14

in general payments reported to CMS, 2019-2025

29 companies · $41K in 2025

The $41K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$37,650.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$24,730.00
Travel and Lodging$24,018.39
Acquisitions$20,693.85
Food and Beverage$8,502.28

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Microvention, INC. $369,403.00 2019-2025 Web Aneurysm Embolization System, Stent, Lvis Junior
Stryker Corporation $78,685.11 2019-2025 Trevo, Surpass Evolve, Target
Medtronic, INC. $66,127.28 2021-2025 Catalyft Pl Expandable Interbody System, Pipeline, Intellis Adaptivestim
Medtronic USA, INC. $61,808.49 2019-2020
Siemens Medical Solutions USA, INC. $13,097.31 2019-2025 Artis Pheno
Sequent Medical, INC. $8,400.00 2019
Imperative Care, INC $2,384.63 2021-2025 Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom Rdl Radial Access System, 103cm
Penumbra, INC. $1,960.61 2019-2024 Penumbra System, Red 72, Benchmark
Relievant Medsystems, INC. $1,051.26 2023 Intracept
Depuy Synthes Sales INC. $840.16 2019-2025 Trufill, Cerepak Uniform, Emboguard
Abbott Laboratories $759.97 2023-2025 Eterna, Proclaim
Rapid Medical LTD $506.46 2022-2023 Comaneci 17, Tigertriever 17 Revascularization Device
Zimmer Biomet Holdings, INC. $290.39 2019-2025 Neuro Plating System, Evo Seeg Electrode
Balt USA, LLC $202.05 2021-2022
Silk Road Medical, INC. $188.66 2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Show all 29 companies
CompanyGeneral paymentsYearsTop products
Medical Device Business Services, INC. $142.22 2024
Boston Scientific Corporation $134.38 2023-2025 Wavewriter Alpha Prime 16, Cds - Mct/Cem Monitoring, Angiojet Ultra 5000a
Qapel Medical INC $128.15 2023-2025
Centinel Spine, LLC $102.76 2019
Globus Medical, INC. $102.09 2025
Mivi Neuroscience, INC. $74.63 2021
Scientia Vascular $57.86 2022-2023
Route 92 Medical, INC. $53.08 2025
Orthofix Medical, INC. $43.19 2019
Amneal Pharmaceuticals LLC $29.54 2019-2020
Mizuho America, INC. $29.32 2020
Neurocrine Biosciences, INC. $18.59 2022
Asahi Intecc USA, INC. $15.46 2019
Astrazeneca Pharmaceuticals LP $14.49 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel A Hoit

$606,651.14

in general payments reported 2019-2025

Years
2019-2025
Top company
Microvention, INC.
Context
The $41K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).

https://glasscript.com/doctor/131178/daniel-a-hoit

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.